Home › Funds › Two Sigma Investments › TRAW
Two Sigma Investments position in TRAW
TRAWS PHARMA INC · Health Care
Latest position (Q1 2026)19.24K sh
Reported value held$35.22K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 67.86K | $173.00K | New |
| Q1 2022 | 63.63K | $117.00K | Reduce |
| Q2 2023 | 157.80K | $186.20K | New |
| Q3 2023 | 124.70K | $88.71K | Reduce |
| Q4 2023 | 39.40K | $29.37K | Reduce |
| Q1 2024 | 37.99K | $38.37K | Reduce |
| Q2 2025 | 16.06K | $23.77K | New |
| Q2 2025 | 16.06K | $23.77K | New |
| Q3 2025 | 22.02K | $40.73K | Add |
| Q4 2025 | 19.24K | $21.75K | Reduce |
| Q1 2026 | 19.24K | $35.22K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding TRAW
- Vanguard Group 87.26K sh · $98.60K · Q4 2025
- Geode Capital Management 111.36K sh · $93.92K · Q2 2026
- Northern Trust Corp 37.45K sh · $31.59K · Q2 2026
- BlackRock Inc 9.94K sh · $8.38K · Q2 2026
- UBS Group AG 3.45K sh · $2.91K · Q2 2026
- Morgan Stanley 468 sh · $395 · Q2 2026
- Fidelity Management & Research (FMR) 2 sh · $2 · Q2 2026